medline.ch Onkologie Urologische Tumoren

	Reply to Daoyuan Li's Words of Wisdom re: Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette GuÃ©rin-naÃ¯ve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.011. Eur Urol Hayne D, Zhang AY, Thomas H, Redfern AD, Davis ID, Stockler MR. PMID: 42168001 [PubMed - as supplied by publisher]
	Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional study. Urol Oncol Aydin AM, Dehghanmanshadi A, Mukhtar V, Siegel ER, Moon S, Biben E, Patel K, Kuykendall K, Fang AM, Langford T, Gokden N, Chang D, Kwon D, Ferguson JE, Peyton CC. PMID: 42167989 [PubMed - as supplied by publisher]
	Is Perirenal Fat an Active Player in Renal Cell Carcinoma Tumorigenesis? A Radiologic-Pathologic Correlation Study. Fr J Urol Gökkurt Y, Karakan T, Kesero, Bayburtluo, Demir DÖ, Y, Kaçan T. PMID: 42167716 [PubMed - as supplied by publisher]
	A DNA Methylation-based algorithm Improves Lung Cancer risk prediction in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Lung Cancer Dawes K, Mills JA, Hoffman RM, Froehlich EM, deBlois K, Sieren JC, Williams C, Merkle S, Long JD, Beach SR, Philibert RA. PMID: 42167026 [PubMed - as supplied by publisher]
	Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer. J Clin Oncol Murthy V, Maitre P, Pal M, Arora A, Phurailatpam R, Sharma R, Gudipudi D, Rajappa S, Pujari L, Bandekar B, Joseph D, Kannan S, Krishnatry R, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Bakshi G, Prakash G. PMID: 42166701 [PubMed - as supplied by publisher]
	Disparities in prostate cancer screening practices among general practitioners and urologists (PROSHADE study): A cross-sectional study. PLoS One Lumbreras B, Parker LA, Alonso-Coello P, Caballero-Romeu JP, Párraga-Martínez I, Prieto L, Moral-Peláez I, Del Campo-Giménez M, Gómez-Pérez L, Cebrián A, López-Garrigós M, Ronda E, Guilabert M, Canelo-Aybar C, Hernández-Aguado I. PMID: 42166422 [PubMed - indexed for MEDLINE]
	Tubulocystic Renal Cell Carcinoma: A Scoping Review of Radiological, Clinicopathological, and Immunohistochemical Features. Urol Int AbuHaweeleh MN, Alhyari A, Abuhayeh N, Emam F, Al-Qudimat AR, Al Rumaihi K, Khalil IA. PMID: 42166387 [PubMed - as supplied by publisher]
	Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma. JAMA Netw Open Shah NJ, Ababio Y, Eccleston A, Rao D, Kelly SP, Chang J, Lucht S, Paydar C, Van Doren BA, Bland E, John W, Giegerich S, Laney J, Feinberg B, Zarrabi KK. PMID: 42166160 [PubMed - indexed for MEDLINE]
	Androgen Receptor Expression in Urothelial Bladder Cancer-A Systematic Review and Meta-Analysis. ANZ J Surg Buckby A, Gholami M, Hong M, O'Callaghan M. PMID: 42165524 [PubMed - as supplied by publisher]
	Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer. Acta Oncol Styrke J, Jellvert Å, Hjälm Eriksson M, Sandin F, Axén E, Jabbar S, Juhl Norgaard K. PMID: 42165189 [PubMed - indexed for MEDLINE]
	Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery. Eur Urol Open Sci Tazawa S, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Narita T, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 42164551 [PubMed]
	The role of CD36 in renal and bladder cancer. Discoveries (Craiova) Pavalean MI, Madan VL, Pavalean MC, Ceafalan LC, Hinescu ME. PMID: 42164471 [PubMed]
	Meta-analysis of efficacy comparisons between standard- and low-dose Bacillus Calmette-Guerin vaccines in managing non-muscular invasive bladder cancer. Oncol Lett Liu X, Bao Y. PMID: 42164465 [PubMed]
	Bioinformatics analysis and experimental approach identify BRD-family gene DSP as a diagnostic and prognostic indicator in bladder cancer. Transl Androl Urol Liu Z, Tan T, Li S, Wang Y. PMID: 42164400 [PubMed]
	Advancing bladder cancer detection: commentary on a urinary DNA methylation diagnostic assay. Transl Androl Urol Duquesne I, Chakra MA, Myers AA, Boormans JL, Hayne D, Brown JA, O'Donnell MA. PMID: 42164398 [PubMed]
	Oncologic outcomes of transurethral resection versus laser excision for non-muscle invasive bladder cancer: a SEER retrospective cohort study. Transl Androl Urol Xia Y, Ma B, Huang T, Liu X. PMID: 42164394 [PubMed]
	Single-port robotic surgery for kidney and upper tract cancer: a narrative review. Transl Androl Urol Daher K, Soputro NA, Younis SK, Al-Bayati A, Bernardino R, Watfa M, Rai S, Wang L, Ghandour R, Kaouk J, Autorino R. PMID: 42164392 [PubMed]
	Machine learning-based integration identifies lactylation biomarkers for prognosis prediction and tumor microenvironment modulation in bladder cancer. Transl Androl Urol Zhou X, Weng L, Sun T, Jiang Q, Zeng F, Xu C, Chang C, Wang Y, Zhou J. PMID: 42164391 [PubMed]
	Association between systemic inflammatory response index and the prognosis of patients with localized and advanced renal cell carcinoma: a systematic review and meta-analysis. Transl Androl Urol Dai Q, Tan X, Huang P, Zhang J, Zhu H. PMID: 42164378 [PubMed]
	Prostate imaging reporting and data system version 2.1 as a predictor of clinically significant and aggressive prostate cancer: a radical prostatectomy-validated study. Transl Androl Urol Pisuchpen N, Eurboonyanun K, O'Shea A, Lahoud RM, Atre ID, Harisinghani M. PMID: 42164375 [PubMed]

Artikel 1 - 20 / 178415

Seite 1 von 8921

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung